A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Hoffmann-La Roche
AstraZeneca
Blueprint Medicines Corporation
Merck Sharp & Dohme LLC
Blueprint Medicines Corporation
Chonnam National University Hospital
Boehringer Ingelheim
Shanghai Chest Hospital
Hunan Province Tumor Hospital
Sun Yat-sen University